Paper Details

Paper Title

A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2014

Bio Mention

APG101, CD95, CD95 ligand, CD95L, CD95L promoter, CpG2, Patient, Patients, glioblastoma, patients, progressive, tumor

Mesh Descriptor

Author Name	Affiliation
Benedikt Wiestler	Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Germany. Clinical Cooperation Unit-Neurooncology, German Cancer Research Center
Andreas von Deimling	Clinical Cooperation Unit-Neuropathology, German Cancer Research Center, Germany. Institute of Neuropathology, University Clinic Heidelberg
Josef Pichler

Column Actions